Evidence map›Paper›PMID 36674864›Full record

ReviewInternational journal of molecular sciences2023

The Phospholipase A2 Superfamily: Structure, Isozymes, Catalysis, Physiologic and Pathologic Roles.

Shibbir Ahmed Khan, Marc A Ilies

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
26.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 170 citations in OpenAlex.

  1. Article
  2. The Phospholipase AJournal of lipid and atherosclerosis · 2026
    Review
  3. Article
  4. iPLAScience advances · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Chinese cobra (Naja atra) SVPLACommunications biology · 2026
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shibbir Ahmed KhanDepartment of Pharmaceutical Sciences and Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19130, USA.
Marc A IliesDepartment of Pharmaceutical Sciences and Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19130, USA.ORCID 0000-0003-0694-411X
Temple University · US

Funding

Interfacially-stabilized polymeric nanosystems for drug deliveryR03EB026189 · NIBIB · TEMPLE UNIV OF THE COMMONWEALTH · PI ILIES, MARC A · 2018 to 2019
$159k
NIH HHS R03EB026189
6 · The paper itself

Abstract

The phospholipase A2 (PLA2) superfamily of phospholipase enzymes hydrolyzes the ester bond at the sn-2 position of the phospholipids, generating a free fatty acid and a lysophospholipid. The PLA2s are amphiphilic in nature and work only at the water/lipid interface, acting on phospholipid assemblies rather than on isolated single phospholipids. The superfamily of PLA2 comprises at least six big families of isoenzymes, based on their structure, location, substrate specificity and physiologic roles. We are reviewing the secreted PLA2 (sPLA2), cytosolic PLA2 (cPLA2), Ca

Indexed as

NeoplasmsPhospholipases A2, SecretoryCatalysisHumansIsoenzymesIsoenzymesPhospholipases A2, Secretoryactivation mechanismcatalysisisozymekineticspathologyphospholipase A2physiologystructuresubcellular localizationsubstrate specificitytissue distribution

Identifiers

PMID36674864
PMCPMC9862071
OpenAlexW4315650748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.